GH Research
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GH Research and other ETFs, options, and stocks.About GHRS
GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders.
CEOVelichka Valcheva
CEOVelichka Valcheva
Employees50
Employees50
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2021
Founded2021
Employees50
Employees50
GHRS Key Statistics
Market cap807.61M
Market cap807.61M
Price-Earnings ratio-17.82
Price-Earnings ratio-17.82
Dividend yield—
Dividend yield—
Average volume206.37K
Average volume206.37K
High today$14.31
High today$14.31
Low today$13.02
Low today$13.02
Open price$13.92
Open price$13.92
Volume239.03K
Volume239.03K
52 Week high$20.50
52 Week high$20.50
52 Week low$6.72
52 Week low$6.72
Stock Snapshot
The current GH Research(GHRS) stock price is $13.04, with a market capitalization of 807.61M. The stock trades at a price-to-earnings (P/E) ratio of -17.82.
During the trading session on 2025-12-14, GH Research(GHRS) shares reached a daily high of $14.31 and a low of $13.02. At a current price of $13.04, the stock is +0.1% higher than the low and still -8.9% under the high.
Trading volume for GH Research(GHRS) stock has reached 239.03K, versus its average volume of 206.37K.
Over the past 52 weeks, GH Research(GHRS) stock has traded between a high of $20.50 and a low of $6.72.
Over the past 52 weeks, GH Research(GHRS) stock has traded between a high of $20.50 and a low of $6.72.
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own GHRS. This list is generated using Robinhood data, and it’s not a recommendation.